Hypertension and Its Treatment at Age 90 Years: Is There an Association with 5-Year Mortality?

Journal of the American Medical Directors Association

Volumn 18, Issue 3, 2017, Pages 277.e13-277.e19

  Stessman, Jochanan ^a,b   Bursztyn, Michael ^a,b   Gershinsky, Yoni ^a,b   Hammerman Rozenberg, Aliza ^a,b   Jacobs, Jeremy M ^a,b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

antihypertensive treatment; cohort; handgrip; Hypertension; mortality; oldest old

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADL DISABILITY; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; COGNITIVE DEFECT; COHORT ANALYSIS; COMORBIDITY; DAILY LIFE ACTIVITY; DEPRESSION; DIASTOLIC BLOOD PRESSURE; EDUCATIONAL STATUS; FEMALE; GRIP STRENGTH; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PREVALENCE; PROSPECTIVE STUDY; SITTING; SURVIVAL; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; VERY ELDERLY; WEIGHT REDUCTION; HAND STRENGTH; HOME FOR THE AGED; ISRAEL; LONGITUDINAL STUDY; MORTALITY; TRENDS;

AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; FEMALE; HAND STRENGTH; HOMES FOR THE AGED; HUMANS; HYPERTENSION; ISRAEL; LONGITUDINAL STUDIES; MALE; MORTALITY; PROSPECTIVE STUDIES;

EID: 85013759597     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2016.12.076     Document Type: Article

References (36)

1. 1 Mozaffarain, D., Benjamin, E.J., Go, A., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2015 update: A report from the American Heart Association. Circulation 131 (2015), e29–e322.
2. 2 Benetos, A., Bulpitt, C.J., Petrovic, M., et al. An expert opinion from the European Society of Hypertension–European Union Geriatric Medicine Society Working Group on the management of hypertension in very old, frail subjects. Hypertension 67 (2016), 820–825.
3. 3 Odden, M.C., Peralta, C.A., Haan, M.N., Covinsky, K.E., Rethinking the association of high blood pressure with mortality in elderly adults: The impact of frailty. Arch Intern Med 172 (2012), 1162–1168.
4. 4 Ogliaru, G., Westendorp, R.G., Mullar, M., et al. Blood pressure and ten-year mortality risk in the Milan Geriatrics 75+ Cohort Study: Role of functional and cognitive status. Age Ageing 44 (2015), 932–937.
5. 5 Benetos, A., Buarois, S., Salvi, P., et al. Blood pressure and pulse wave velocity in the institutionalized elderly aged 80 and over: Baseline of the PARTAGE study. J Hypertens 28 (2010), 41–50.
6. 6 Benetos, A., Gautier, S., Labat, C., et al. Mortality and cardiovascular events are best predicted by low central/peripheral pulse pressure amplification and not by high blood pressure levels in elderly nursing home subjects: The PARTAGE study (Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population) study. J Am Coll Cardiol 60 (2012), 1503–1511.
7. 7 Benetos, A., Labat, C., Rossignol, P., et al. Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: The PARTAGE Study. JAMA Intern Med 175 (2015), 989–995.
8. 8 Mossello, E., Peiraccioli, M., Nesti, N., et al. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. JAMA Intern Med 175 (2015), 578–585.
9. 9 Beckett, N.S., Peters, R., Flestcher, A.E., et al. Treatment of hypertension in patients 80 years of age or older. N Eng J Med 358 (2008), 1887–1898.
10. 10 Wright, J.T. Jr., Williamson, J.D., Whelton, P.K., et al. SPRINT Research Group. A randomized trial of intensive versus standardized blood-pressure control. N Eng J Med 373 (2015), 2103–2116.
11. 11 Williamson, J.D., Supiano, M.A., Applegate, W.B., et al., SPRINT Research Group. Intensive vs standardized blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years. A randomized clinical trial. JAMA 315 (2016), 2673–2682.
12. 12 Mancia, G., Fagard, R., Narkiewicz, K., et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34 (2013), 2159–2219.
13. 13 James, P.A., Oparil, S., Carter, B.L., et al. 2014 Evidence-based guidelines for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311 (2014), 507–520.
14. 14 Warwick, J., Falaschetti, E., Rockwood, K., et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: An investigation of the impact of frailty upon treatment effect in the Hypertension in the Very Elderly Trial (HYVET) study, a double-blind placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med, 13, 2015, 78.
15. 15 Pajewski, N.M., Williamson, J.D., Applegate, W.B., et al. Characterizing frailty status in the systolic blood pressure intervention trial. J Gerontol A Biol Sci Med Sci 71 (2016), 649–655.
16. 16 Stessman, J., Cohen, A., Ginsberg, G.M., et al. The Jerusalem Seventy-year-old longitudinal study, I: Description of the initial cross-sectional survey. Eur J Epidemiol 11 (1995), 675–684.
17. 17 Jacobs, J.M., Cohen, A., Bursztyn, M., et al. Cohort profile: The Jerusalem Longitudinal Cohort Study. Int J Epidemiol 38 (2009), 1464–1469.
18. 18 Cohen, A., Stessman, J., Ginsberg, G.M., et al. Jerusalem 70-Year-Old Longitudinal Study, II: Background results from the initial home interview. Eur J Epidemiol 11 (1995), 685–692.
19. 19 Jacobs, J.M., Maaravi, Y., Cohen, A., et al. Changing profile of health and function from age 70 to 85 years. Gerontology 58 (2012), 313–321.
20. 20 Derogatis, L.R., Melisaratos, N., The Brief Symptom Inventory: An introductory report. Psychol Med 13 (1983), 596–605.
21. 21 Folstein, M.F., Folstein, S.E., McHugh, P.R., Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975), 189–198.
22. 22 Stessman, J., Hammerman-Rozenberg, R., Cohen, A., et al. Physical activity, function, and longevity among the very old. Arch Intern Med 169 (2009), 1476–1483.
23. 23 Katz, S., Ford, A.B., Moskowitz, R.W., et al. Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA 185 (1963), 914–919.
24. 24 Stessman, J., Hammerman-Rozenberg, R., Maaravi, Y., Cohen, A., The impact of exercise on ease of performance of ADL and IADL from age 70-77: The Jerusalem Longitudinal Study. J Am Geriatr Soc 50 (2002), 1934–1938.
25. 25 Roberts, H.C., Denison, H.J., Martin, H.J., et al. A review of the measurement of grip strength in clinical and epidemiological studies: Towards a standardized approach. Age Ageing 40 (2011), 423–429.
26. 26 Stessman J, Rottenberg Y, Fischer M, et al. Handgrip strength in the old and very old: Mood, cognition, function and mortality. J Am Geriatr Soc. In Press.
27. 27 Studenski, S.A., Peters, K.W., Alley, D.E., et al. The FNIH Sarcopenia Project: Rationale and study description. J Gerontol A Biol Sci Med Sci 5 (2014), 547–558.
28. 28 Alley, D.E., Shardell, M.D., Peters, K.W., et al. Grip strength cutoff points for the identification of clinically relevant weakness. J Gerontol A Biol Sci Med Sci 5 (2014), 559–566.
29. 29 World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). 1977, World Health Organization, Geneva, Switzerland.
30. 30 Jacobs, J.M., Stessman, J., Ein-Mor, E., Bursztyn. Hypertension and 5 year mortality among 85 year olds: The Jerusalem Longitudinal Study. J Am Med Dir Assoc 13 (2012), 759.e1–759.e6.
31. 31 Collerton, J., Davies, K., Jagger, C., et al. Health and diseases in 85 year olds: Baseline findings from the Newcastle 85+ cohort study. Br Med J, 399, 2009, b4904.
32. 32 Westendorp, R.G., Leiden research program on aging. Exp Gerontol 37 (2002), 609–614.
33. 33 Brodsky J, Shnoor Y, Be'er S, eds. The Elderly in Israel: Statistical Abstract 2014. Available at: www/jdc/org/il/mashav. Accessed December 13, 2016.
34. 34 World Health Statistics 2016: Monitoring health for the SDGs Annex B: tables of health statistics by country, WHO region and globally, 2016, World Health Organization, Geneva, Switzerland Available at: http://www.who.int/gho/publications/world_health_statistics/2016/Annex_B/en/. Accessed December 13, 2016.
35. 35 Sourial, N., Bergman, H., Karunananthan, S., et al. Contribution of frailty markers in explaining differences among individuals in 5 samples of older people. J Gerontol A Biol Sci Med Sci 67 (2012), 1197–1204.
36. 36 Bursztyn, M., Leibowitz, D., Stessman-Lande, I., et al. Left ventricular mass as a risk factor in the oldest old. J Clin Hypertens 17 (2015), 874–879.